Blood cancer researcher (IMAGE)
Caption
Gege Gui, a research scientist at the Fralin Biomedical Research Institute Cancer Center in Washington, D.C., was first author of a study to refine relapse prediction in patients with a rare blood cancer.
Credit
Virginia Tech
Usage Restrictions
None
License
Original content